Capivasertib (AZD5363) in combination with fulvestrant in PTEN-mutant ER+ metastatic breast cancer Meeting Abstract


Authors: Smyth, L. M.; Batist, G.; Meric-Bernstam, F.; Kabos, P.; Spanggaard, I.; Lluch, A.; Schram, A.; Varga, A.; Wong, A.; Ambrose, H.; Barnicle, A.; Carr, T. H.; de Bruin, E. C.; Salinas-Souza, C.; Foxley, A.; Hauser, J.; Lindemann, J. P. O.; Maudsley, R.; McEwen, R.; Moschetta, M.; Roudier, M.; Schiavon, G.; Razavi, P.; Banerji, U.; Chandarlapaty, S.; Baselga, J.; Hyman, D. M.
Abstract Title: Capivasertib (AZD5363) in combination with fulvestrant in PTEN-mutant ER+ metastatic breast cancer
Meeting Title: 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 80
Issue: 4 Suppl.
Meeting Dates: 2019 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2020-02-01
Language: English
ACCESSION: WOS:000527012500326
DOI: 10.1158/1538-7445.Sabcs19-p1-19-05
PROVIDER: wos
Notes: Meeting Abstract: P1-19-05 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Hyman
    354 Hyman
  2. Alison Michele Schram
    122 Schram
  3. Jose T Baselga
    484 Baselga
  4. Pedram Razavi
    172 Razavi
  5. Lillian   Smyth
    42 Smyth